Taar1 gene variants have a causal role in methamphetamine intake and response and interact with Oprm1

  1. Alexandra M Stafford
  2. Cheryl Reed
  3. Harue Baba
  4. Nicole AR Walter
  5. John RK Mootz
  6. Robert W Williams
  7. Kim A Neve
  8. Lev M Fedorov
  9. Aaron J Janowsky
  10. Tamara J Phillips  Is a corresponding author
  1. Oregon Health and Science University, United States
  2. Oregon National Primate Research Center, United States
  3. University of Tennessee Health Sciences Center, United States

Abstract

We identified a locus on mouse chromosome 10 that accounts for 60% of the genetic variance in methamphetamine intake in mice selectively bred for high versus low methamphetamine consumption. We nominated the trace amine-associated receptor 1 gene, Taar1, as the strongest candidate and identified regulation of the mu-opioid receptor 1 gene, Oprm1, as another contributor. This study exploited CRISPR-Cas9 to test the causal role of Taar1 in methamphetamine intake and a genetically-associated thermal response to methamphetamine. The methamphetamine-related traits were rescued, converting them to levels found in methamphetamine-avoiding animals. We used a family of recombinant inbred mouse strains for interval mapping and to examine independent and epistatic effects of Taar1 and Oprm1. Both methamphetamine intake and the thermal response mapped to Taar1 and the independent effect of Taar1 was dependent on genotype at Oprm1. Our findings encourage investigation of the contribution of Taar1 and Oprm1 variants to human methamphetamine addiction.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 2 through 8.

Article and author information

Author details

  1. Alexandra M Stafford

    Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4045-1888
  2. Cheryl Reed

    Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Harue Baba

    Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Nicole AR Walter

    Division of Neuroscience, Oregon National Primate Research Center, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. John RK Mootz

    Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Robert W Williams

    Department of Genetics, Genomics and Informatics, University of Tennessee Health Sciences Center, Memphis, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Kim A Neve

    Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0109-7345
  8. Lev M Fedorov

    Transgenic Mouse Models Shared Resource, Knight Cancer Institute, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Aaron J Janowsky

    Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Tamara J Phillips

    Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, United States
    For correspondence
    phillipt@ohsu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7350-6323

Funding

National Institute on Drug Abuse (R01 DA046081)

  • Tamara J Phillips

Veterans Affairs Research Career Scientist Program (Career Scientist award)

  • Tamara J Phillips

Veterans Affairs Research Career Scientist Program (Career Scientist award)

  • Aaron J Janowsky

University of Tennessee Center for Integrative and Translational Science (Center support)

  • Robert W Williams

National Institute on Drug Abuse (P50 DA018165)

  • Aaron J Janowsky

National Institute on Drug Abuse (P50 DA018165)

  • Tamara J Phillips

National Institute on Drug Abuse (U01 DA041579)

  • Tamara J Phillips

National Institute on Drug Abuse (P30 DA044223)

  • Robert W Williams

Department of Veterans Affairs (I01BX002106)

  • Tamara J Phillips

Department of Veterans Affairs (I01BX002758)

  • Aaron J Janowsky

Department of Veterans Affairs (I01BX003279)

  • Kim A Neve

Oregon Health & Science University-Pilot Funding to the Transgenic Mouse Models Shared Resource (University Shared Resource award)

  • Kim A Neve

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.

Ethics

Animal experimentation: All experiments were performed in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the VA Portland Health Care System (VAPORHCS), protocol numbers 3169-14 and 3169-16.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 2,153
    views
  • 466
    downloads
  • 24
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Alexandra M Stafford
  2. Cheryl Reed
  3. Harue Baba
  4. Nicole AR Walter
  5. John RK Mootz
  6. Robert W Williams
  7. Kim A Neve
  8. Lev M Fedorov
  9. Aaron J Janowsky
  10. Tamara J Phillips
(2019)
Taar1 gene variants have a causal role in methamphetamine intake and response and interact with Oprm1
eLife 8:e46472.
https://doi.org/10.7554/eLife.46472

Share this article

https://doi.org/10.7554/eLife.46472

Further reading

    1. Developmental Biology
    2. Genetics and Genomics
    Anne-Sophie Pepin, Patrycja A Jazwiec ... Sarah Kimmins
    Research Article Updated

    Paternal obesity has been implicated in adult-onset metabolic disease in offspring. However, the molecular mechanisms driving these paternal effects and the developmental processes involved remain poorly understood. One underexplored possibility is the role of paternally induced effects on placenta development and function. To address this, we investigated paternal high-fat diet-induced obesity in relation to sperm histone H3 lysine 4 tri-methylation signatures, the placenta transcriptome, and cellular composition. C57BL6/J male mice were fed either a control or high-fat diet for 10 weeks beginning at 6 weeks of age. Males were timed-mated with control-fed C57BL6/J females to generate pregnancies, followed by collection of sperm, and placentas at embryonic day (E)14.5. Chromatin immunoprecipitation targeting histone H3 lysine 4 tri-methylation (H3K4me3) followed by sequencing (ChIP-seq) was performed on sperm to define obesity-associated changes in enrichment. Paternal obesity corresponded with altered sperm H3K4me3 at promoters of genes involved in metabolism and development. Notably, altered sperm H3K4me3 was also localized at placental enhancers. Bulk RNA-sequencing on placentas revealed paternal obesity-associated sex-specific changes in expression of genes involved in hypoxic processes such as angiogenesis, nutrient transport, and imprinted genes, with a subset of de-regulated genes showing changes in H3K4me3 in sperm at corresponding promoters. Paternal obesity was also linked to impaired placenta development; specifically, a deconvolution analysis revealed altered trophoblast cell lineage specification. These findings implicate paternal obesity effects on placenta development and function as one potential developmental route to offspring metabolic disease.

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics
    Federico A Vignale, Andrea Hernandez Garcia ... Adrian G Turjanski
    Research Article

    Yerba mate (YM, Ilex paraguariensis) is an economically important crop marketed for the elaboration of mate, the third-most widely consumed caffeine-containing infusion worldwide. Here, we report the first genome assembly of this species, which has a total length of 1.06 Gb and contains 53,390 protein-coding genes. Comparative analyses revealed that the large YM genome size is partly due to a whole-genome duplication (Ip-α) during the early evolutionary history of Ilex, in addition to the hexaploidization event (γ) shared by core eudicots. Characterization of the genome allowed us to clone the genes encoding methyltransferase enzymes that catalyse multiple reactions required for caffeine production. To our surprise, this species has converged upon a different biochemical pathway compared to that of coffee and tea. In order to gain insight into the structural basis for the convergent enzyme activities, we obtained a crystal structure for the terminal enzyme in the pathway that forms caffeine. The structure reveals that convergent solutions have evolved for substrate positioning because different amino acid residues facilitate a different substrate orientation such that efficient methylation occurs in the independently evolved enzymes in YM and coffee. While our results show phylogenomic constraint limits the genes coopted for convergence of caffeine biosynthesis, the X-ray diffraction data suggest structural constraints are minimal for the convergent evolution of individual reactions.